Skip to main content
Premium Trial:

Request an Annual Quote

Genesis Swaps Software Rights for Stake in Real Time Genomics

NEW YORK (GenomeWeb News) — Genesis Research and Development will trade its rights to royalties on the sale of a genomics data querying software package for a stake in start-up bioinformatics company Real Time Genomics.

Auckland, New Zealand-based Genesis said today that it is converting the royalty rights to NetValue's SLIM Search software, which is based on Genesis' Cartesian technology, in exchange for a 10 percent stake in the Real Time Genomics. Genesis' interest will be held by New Zealand holding company Gene Value.

The SLIM Search software can search and analyze short genomics reads, data generated by 454 Life Sciences' instruments, and 10k and larger reads in real-time, the company said.